High-risk Human Papillomavirus Testing for Cervical Cancer Screening

被引：2
|
作者：
Totten, Stephanie P. S. [1 ,2 ]
Romero, Joan Miguel [1 ,3 ]
机构：
[1] McGill Univ, Fac Med, Montreal, PQ, Canada
[2] Lady Davis Inst Med Res, Montreal, PQ, Canada
[3] Rosalind & Morris Goodman Canc Res Ctr, 1160 Pine Ave W,Room 611D, Montreal, PQ H3A 1A3, Canada
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 07期
关键词：
D O I：
10.1001/jamaoncol.2021.0735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1066 / 1067
页数：9
相关论文
共 50 条
  • [31] Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus
    Luckett, Rebecca
    Mogowa, Neo
    Li, Howard J.
    Erlinger, Adrienne
    Hacker, Michele R.
    Esselen, Katharine
    Feldman, Sarah
    Shapiro, Roger
    Morroni, Chelsea
    Ramogola-Masire, Doreen
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (04): : 840 - 849
  • [32] Human Papillomavirus Testing for Primary Cervical Cancer Screening
    Runowicz, Carolyn D.
    Garozzo, Stephanie
    CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 533 - 537
  • [33] Human papillomavirus testing for primary cervical cancer screening
    Cuzick, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01): : 108 - 109
  • [34] Human Papillomavirus DNA Testing for Cervical Cancer Screening
    Belinson, Suzanne E.
    Belinson, Jerome L.
    MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (04) : 215 - 222
  • [35] Primary cervical screening with high risk human papillomavirus testing: observational study
    Rebolj, Matejka
    Rimmer, Janet
    Denton, Karin
    Tidy, John
    Mathews, Christopher
    Ellis, Kay
    Smith, John
    Evans, Chris
    Giles, Thomas
    Frew, Viki
    Tyler, Xenia
    Sargent, Alexandra
    Parker, Janet
    Holbrook, Miles
    Hunt, Katherine
    Tidbury, Penny
    Levine, Tanya
    Smith, David
    Patnick, Julietta
    Stubbs, Ruth
    Moss, Sue
    Kitchener, Henry
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
  • [36] Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis
    Berkhof, J
    de Bruijne, MC
    Zielinski, GD
    Bulkmans, NWJ
    Rozendaal, L
    Snijders, PJF
    Verheijen, RHM
    Meijer, CJLM
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) : 1759 - 1768
  • [37] Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
    Berkhof, J
    de Bruijne, MC
    Zielinski, GD
    Meijer, CJLM
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (02) : 268 - 275
  • [38] Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening
    Cenci, Maria
    Rossi, Francesca
    Pisani, Tiziana
    IN VIVO, 2023, 37 (05): : 2161 - 2165
  • [39] The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening
    Schmeink, Channa E.
    Bekkers, Ruud L. M.
    Massuger, Leon F. A. G.
    Melchers, Willem J. G.
    REVIEWS IN MEDICAL VIROLOGY, 2011, 21 (03) : 139 - 153
  • [40] Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening
    Oh, YL
    Shin, KJ
    Han, J
    Kim, DS
    CYTOPATHOLOGY, 2001, 12 (02) : 75 - 83
12345